Standardization

Pharmacological activity

MSM (Méthylsulfonylméthane)

• Analgesic;
• Antispasmodic and anti-inflammatory.

FEVERFEW (Tanacetum Parthenium)

• Antimigraine, anti-inflammatory and analgesic;
• Serotonin inhibitor;
• Antiemetic (against nauseas).

GRIFFONIA (Griffonia Simplicifolia)

• Serotonin precursor;
• Controls the pituitary gland activities;
• Supports the correct function of the nervous system.

WHITE WILLOW (Salix Alba)

• Anti-inflammatory and analgesic;
• Antipyretic.

GINGER (Zingiber Officinale)

• Antalgic, anti-inflammatory and anti-emetic;
• Tonic for the nervous system.

BUTTERBUR (Petasites Hybridus)

• Antimigraine;
• Anti-inflammatory and antispasmodic.

• Prolonged use: Take 1½ teaspoon (7,5 ml) once daily.
•  When a crisis is suspected (during the aura): Use pure. Take 1½ teaspoon (7,5 ml) and keep under the tongue for 30 to 60 seconds, then swallow. The more quickly this treatment is carried out, the better the possibility to abort the migraine. Repeat once or twice if needed, 15 and 30 minutes after the beginning of the symptoms.
• Acute migraine crisis: Take 1½ teaspoon (7,5 ml) 1 to 4 times a day. Then, follow the indications for prolonged use.

• Suffer of migraines with or without aura;
• Want to reduce the duration, the intensity and the frequency of migraine crisis;
• Wish to relieve the pain.

CONTRAINDICATIONS

• Allergies to the ingredients of the formulation;
• Allergies to asteracees, acetylsalicylic acid (Aspirin®), allergy (ASA) and of its derivatives, or to any other ingredient of the formulation;
• Avoid giving in the cases of a pregnancy or breastfeeding;
• In the event of serious illness or consumption of other medicines, do not consume this product without the consent of your doctor or your healthcare professional.

PRECAUTIONS

• Pre-operation period (minimum of 2 weeks before surgery).

• Renal disorders;
• Hepatic precedent;
• Gallstones;
• Allergies to composite flowers and acetylsalicylic acid;
• Hemophilia;
• Before combining with any other product or medicine;
• Avoid giving to children under 12 years of age and to pregnant or breastfeeding women without the advice of a health practitioner;
• Cease the use and consult a health practitioner if the symptoms persist or if undesirable effects should occur.
• In the event of serious illness or consumption of other medicines, do not consume this product without the consent of your doctor or your healthcare professional.

MEDICINAL INTERACTIONS

• ISRS, anxiolytics (antidepressants, lithium) and beta-blockers;
• Interact with chemotherapy;
• Anticoagulants such as warfarin or Aspirin®;
• This product increases the effect of St. John’s wort;
• May increase the effect of papaverin (antispasmodic);
• May interact with cyclosporine (anti-tumour) and thiazide (diuretic).

KNOWN UNDESIRABLE EFFECTS

• Cease the use if you suffer from: abdominal pains, nausea, diarrhea, heartburn or if you experience mouth or throat irritation.

Q.    Does this product work on all types of migraines?

Q.    What is the difference between a migraine and a headache?

• Barnes J, Anderson LA, Phillipson JD. Herbal Medicines: A guide for healthcare professionals. 2nd ed. London (UK): Pharmaceutical Press; 2002.
• Bradley PR, editor. British Herbal Compendium, Vol 1. Bournemouth (UK): British Herbal Medicine Association; 1992.
• Brinker F. Herb Contraindication and Drug Interactions. 3rd edition. Sandy (OR): Eclectic Medical Publications; 2001.
• Duke JA. Handbook of medicinal herbs. Boca Raton (FL): CRC Press; 1985.
• European Scientific Cooperative on Phytotherapy (ESCOP). Monographs on the Medicinal Uses of Plant Drugs. Exeter (UK): ESCOP; 1999.
• Gruenwald J, Bendler T, Jaenicke C, editors. PDR for Herbal Medicines. Montvale (NJ): Medical Economics Company; 1998.
• Johnson ES, Kadam NP, Hylands DM, et collab. Efficacy of feverfew as prophylactic treatment of migraine. British Medical Journal 1985;291: 596-73.
• McGuffin M, Kartesz JT, Leung AY, Tucker AO. Herbs of Commerce. 2nd ed. USA: The American Herbal Products Association; 2000.
• Miller LG. Herbal medicinals: Selected clinical considerations focusing on known or potential drug- herb interactions. Archives of Internal Medicine 1998;158(20): 2200-11.
• USDA, ARS, National Genetic Resources Program. Germoplasm Resources Information Network – (GRIN). Tanacetum parthenium Backon J. Ginger as an antiemetic: possible side effects due to its thromboxane synthetase activity. Anaesthesia 1991;46:705-706.
• Bone ME, et al. Ginger root, a new antiemetic. The effect of ginger root on postoperative nausea and vomiting after major gynaecological surgery. Anaesthesia 1990; 45:669-671.
• Boon H, Smith M. The Botanical Pharmacy: The Pharmacology of 47 Common Herbs. Kingston (Ontario):Quarry Press Inc;1999.
• Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Klein S, et al., editors. The Complete German Commission E Monographs. Boston (MA); Integrative MedicineCommunications;1998.
• Combest WL. Ginger. US Pharmacist 1998 Feb:74-86.
• Desai HG, Kalro RH, Choksi AP. Effect of ginger and garlic on DNA content of gastric aspirate. Ind J Med Res 1990;92:139-41.
• Ellingwood F. American Materia Medica, Therapeutics and Pharmacognosy. Sandy (OR): Eclectic Medical Publications; 1919.
• Felter HW, Lloyd JU. King's American Dispensatory. 18th edition. Sandy (OR): Eclectic Medical Publications; 1983.
• Fischer-Rasmussen W, Kjaer SK, Dahl C, Asping U. Ginger treatment of hyperemesis gravidarum. European journal of obstetrics, gynaecology, and reproductive biology 1991;38:19-24.
• Grontved A, Brask T, Kambskard J, Hentzer E. Ginger root against seasickness; a controlled trial on the open sea. Acta otolaryngology 1988;105:45-49.
• Jain SK, Tarafder CR. Medicinal Plant-lore of the Santals. (A Revival of P.O. Bodding=s Work). Econ. Bot 1970;24:241.
• Jellin JM, Batz F, Hitchens K. Pharmacist's Letter / Prescriber's Letter Natural Medicines Comprehensive Database. Stockton (CA):Therapeutic Research Faculty;2003.
• Lumb AB. Effect of dried ginger on human platelet function. Thromb Haemost 1994;71:110-111.
• Mowrey DB, Clayson DE. Motion sickness, ginger, and psychophysics. Lancet 1982:655-657.
• Reynolds JEF, editor. Martindale the Extra Phamacopoeia. 30th ed. London (UK):Pharmaceutical Press;1999.
• Riebenfeld D, Borzone L. Randomized double-blind study comparing Ginger (Zintona®) and Dimenhydrinate in motion sickness. HNR 1999;2(6):98-101.
• Schmid R, et al. Comparison of seven commonly used agents for prophylaxis of seasickness. Journal of travel medicine 1994;1:203-206.
• Srivastava KC. Effects of onion and ginger consumption on platelet thromboxane production in humans. Prostaglandins Leukot and Essent Fatty Acids 1989;35:183-185.
• Stewart JJ, Wood MJ, Wood CD, Mims ME. Effects of ginger on motion sickness susceptibility and gastric function. Pharmacology 1991;42:111-20.
• USDA, ARS, National Genetic Resources Program. Germoplasm Resources Information Network – (GRIN). Zingiber officinale.
• World Health Organization (WHO). WHO Monographs on Selected Medicinal Plants. Geneva (Switzerland): World Health Organization;1999.
• Hoffmann, D., Medical Herbalism: The Science and Practice of Herbal Medicine, Healing Arts Press, 2003
• Fetrow, C.W., Avila, J.A., Professional’s Handbook of Complementary & Alternative Medicines, Second edition, Springhouse Corporation, Pennsylvania, 2001.
• Brinker F., Herb Contraindications & Drug Interactions With Extensive Appendices Addressing Specific Conditions, Herb Effects, Critical Medication and Nutritional Supplements, Third Edition, 2001, Oregon, USA.
• Blumenthal M, Goldberg A, Brinckmann J (Ed). Expanded Commission E Monographs, American Botanical Council, publié en collaboration avec Integrative Medicine Communications, United States, 2000.
• DerMarderosian A et al. Willow Bark, The Review of Natural Products - Facts and Comparisons, United States, 2000.
• European Scientific Cooperative on Phytotherapy (Ed). Salicis cortex, ESCOP Monographs on the Medicinal Uses of Plants Drugs, Centre for Complementary Health Studies, Université d'Exeter, Great Britain, 1997.
• National Library of Medicine (Ed). PubMed, NCBI. www.ncbi.nlm.nih.gov
• The Natural Pharmacist (Ed). Natural Products Encyclopedia, Herbs & Supplements - White Willow, ConsumerLab.com. www.consumerlab.com
• Schulz V, Hänsel R, Tyler VE. Rational Phytotherapy - A Physicians' Guide to Herbal Medicine, fourth edition, Springer, Allemagne, 2001.
• Therapeutic Research Faculty (Ed). Willow Bark, Natural Medicines Comprehensive Database. www.naturaldatabase.com
• Weiss RF. Herbal Medicine, Beaconsfield Publishers, Angleterre, 1988. Mills SY, Jacoby RK, Chacksfield M, Willoughby M. Effect of a proprietary herbal medicine on the relief of chronic arthritic pain: a double-blind study.Br J Rheumatol 1996 Sep;35(9):874-8.
• Chrubasik S, Eisenberg E, Balan E, Weinberger T, Luzzati R, Conradt C. Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study.Am J Med 2000 Jul;109(1):9-14.
• Schmid B, Ludtke R, Selbmann HK, Kotter I, Tschirdewahn B, Schaffner W, Heide L. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double blind clinical trial.Phytother Res 2001 Jun;15(4):344-50.
• Chrubasik S, Kunzel O, Black A, Conradt C, Kerschbaumer F. Potential economic impact of using a proprietary willow bark extract in outpatient treatment of low back pain: an open non-randomized study. Phytomedicine. 2001 Jul;8(4):241-51.
• Krivoy N, Pavlotzky E, Chrubasik S, Eisenberg E, Brook G. Effect of salicis cortex extract on human platelet aggregation.Planta Med 2001 Apr;67(3):209-12.
• Blumenthal M, Goldberg A, Brinckmann J (Ed). Expanded Commission E Monographs, American Botanical Council, publié en collaboration avec Integrative Medicine Communications, United States, 2000, p. 410.
• Chrubasik S, Kunzel O, Model A, Conradt C, Black A. Treatment of low back pain with a herbal or synthetic anti-rheumatic: a randomized controlled study. Willow bark extract for low back pain. Rheumatology (Oxford). 2001 Dec;40(12):1388-93.
• Lawrence RM. Methyl-sulfonyl-methane (MSM). A double-blind study of its use in degenerative arthritis, 1998. (Non published in a scientific journal revised by pars). www.msm.com
• Lawrence RM, Sanchez D, Grosman M. LIGNISUL MSM (Methylsulfonylmethane) in the treatment of acute athletic injuries. (Non published in a scientific journal revised by pars). www.msm.com
• Lawrence RM. The Effectiveness of the Use of Oral LIGNISULmsm (Methylsulfonylmethane) Supplementation on Hair & Nail Health. (Non published in a scientific journal revised by pars). www.msm.com
• Jacob SW. The current status on the use of a new pharmacologic approach (dimethyl sulfone) for the relief of snoring. Oregon Health Sciences University. Non publié. 1999. (summary in Lefrançois P., MSM: a hope for the athletes? Natural Health Products Report, vol.9, no 6, p.23).
• Barrager E, Veltmann JR Jr, Schauss AG, Schiller RN. A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis.J Altern Complement Med. 2002 Apr;8(2):167-73.
• ConsumerLab. Product Review: Joint Supplements (Glucosamine).www.consumerlab.com

• Migraine crisis: Aurorus may be combined with Allevia  which acts as an analgesic. Individuals whose migraines are started by stressful situations should combine Aurorus with Relaximum . Indeed, by reducing the symptoms of stress and the disadvantages associated with it, you will benefit from this combination by noting a reduction in migraine episodes.

• Migraines can often be associated with a slow metabolism, where there is bad hepatic management. D-Tox i is designed to “clean” the system. A one month cure is often very beneficial to improve the frequence of  migraine crisis and to reduce their intensity. Often, following detoxication, food consumption becomes less problematic. Sometimes the combination with   AntiOxy Bio  reduces free radicals which allows the body to react better.